Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmacy Benefits Management: research reports

1594

Find the information you need on the pharmacy benefits management market. Our collection of research reports provides insights into pharmacy pricing and reimbursement and prescribing trends, segmentation, and size and growth in the US and global markets are also featured.

RSS Feeds

Pharmacy Benefits Management market research reports and industry analysis

Pharmacy Benefit Management in the US - Industry Market Research Report
7/18/2012 | published by: IBISWorld
... visits, which will yield a higher number of prescriptions filled. As the median age of the US population continues to rise, more Americans will rely on medications, increasing demand for the industry's services from insurers ...  |  more...
$910.00
Pharma Wholesale and Distribution Market: World Outlook 2012-2022
6/19/2012 | published by: Visiongain
... environment. It lets you discover projected revenues at overall world market, main submarket, company and national level to 2022. You see forecasts of world-level submarkets to 2022, finding potential revenue: Original-branded drugs Generic drugs. How ...  |  more...
$2,739.00
US Pharmacy Benefit Management (PBM) Industry Report: 2011 Edition
11/1/2011 | published by: Koncept Analytics
... margin business. The US prescription volume and expenditure has been increasing over the past years. The number of drugs coming into the US market is expected to speed up in future. More effective strategies are ...  |  more...
$800.00
Frost & Sullivan Speaks Candidly with U.S. Pharmacists
5/2/2011 | published by: Frost & Sullivan
... topics of interest to pharmacists. Questions and discussions were designed to gage both short-term and long-term trends and impacts. Questions posed to the pharmacist panel covered the following main topics: the role of the pharmacist, ...  |  more...
$10,000.00
Reforms to the Pharmaceutical Benefits Scheme in Australia
2/4/2011 | published by: Datamonitor
... others. Features and benefits Overview of the role and function of the Pharmaceutical Benefits Scheme in Australia. Summary of all major aspects of PBS reform between 2007 and 2011. Assessment of the potential impacts of ...  |  more...
$500.00
Pharmacy Benefit Managers (PBMs) are Critical for Ensuring Quality of Pharmaceutical Care and Controlling Drug Expenditures
1/30/2011 | published by: GlobalData
... provides key data, information role benefits and concern surroundings of Pharmacy Benefit Managers. Scope Data and information on noval therapyon PBM market Reasons to buy Develop business strategies by understanding the trends and developments in ...  |  more...
$500.00
Catalyst Health Solutions, Inc. - SWOT Analysis
11/30/2010 | published by: MarketLine
... history and products, and provides summary analysis of its key revenue lines and strategy. Catalyst Health Solutions (formerly known as HealthExtras), through its subsidiaries, provides pharmacy benefit management (PBM) services and supplemental benefits. The company ...  |  more...
$125.00
Pharmacy Automation: Technologies and Global Markets
9/1/2010 | published by: BCC Research
... expected to grow at a 4.6% compound annual growth rate (CAGR) to reach $2.7 billion in 2015. Inpatient pharmacy automation revenues account for the larger share of the market, with sales expected to reach $1.7 ...  |  more...
$4,850.00
European Markets for Pharmacy Automation Systems
5/4/2010 | published by: Frost & Sullivan
... segments are forecasted. In addition, an in-depth analysis of the competitive situation including vendors' market shares is performed. The base year is 2009 with forecasts running through 2016. The market is further divided into three ...  |  more...
$6,000.00
Drug Benefit Trends in the United States
3/30/2009 | published by: Decision Resources
... and assesses the outlook and implications for the pharmaceutical industry. Get the Answers You Need to Shape Your Strategy Unlike the other major pharmaceutical markets, the United States relies on the private sector for most ...  |  more...
$4,600.00
Pricing and Reimbursement of Fixed-Dose Combination Drugs in the United States
12/3/2008 | published by: Decision Resources
... offer pharmaceutical companies a relatively easy and inexpensive way to bring new drugs to market. However, new surveys of 40 managed care organization (MCO) medical/pharmacy directors and more than 400 physicians, together with a detailed ...  |  more...
$4,600.00
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2007
1/31/2008 | published by: Decision Resources
... uninsured and universal coverage. A public consultation on the future of pharmaceuticals highlighted the challenges confronting drug manufacturers in Europe, while the Japanese government seemingly changed course on overhauling its pharmaceutical pricing and reimbursement system. ...  |  more...
$4,600.00
The Increasing Influence of Payers, Providers, and Patients on the U.S. Pharmaceutical Market
10/29/2007 | published by: Decision Resources
... choices through their control of formularies and reimbursement restrictions. However, formulary designs are rapidly changing, and reimbursement restrictions are being used more frequently. And although physicians remain the ultimate decision makers regarding which medications patients ...  |  more...
$4,600.00
Pharmaceutical Innovation: Is It Really Rewarded?
6/15/2007 | published by: Decision Resources
... on overtaxed health care systems. Thus, the essential challenge for governments and other payers is to strike a balance between the benefi ts and costs of making innovative medicines more widely available. Get the Answers ...  |  more...
$4,600.00
Specialty Pharmaceuticals in the United States: Changing Patterns of Distribution and Reimbursement
3/26/2007 | published by: Decision Resources
... key stakeholders: specialty pharmacy vendors, payers, physicians, patients, and drug manufacturers. These players will benefit from a buoyant U.S. market for specialty drugs, which is set to grow vigorously for decades to come. Get the ...  |  more...
$4,600.00
ExpressScripts: Sales Strategy Analysis
9/1/2006 | published by: RocSearch
... highlights the recent developments in the company. A key part of this report is an analysis of Express Scripts’ value chain and an assessment of the key business strategies that have driven the company’s growth.  |  more...
$950.00
PharmaCare: Sales Strategy Analysis
9/1/2006 | published by: RocSearch
... and after discussing the company’s business model, it goes on to analyze the company’s sales and competitive strategies in detail. The company’s key focus areas include: Capturing large new contracts Growth in specialty business Leveraging ...  |  more...
$950.00
National Medical Health Card Systems, Inc.: Sales Strategy
5/1/2006 | published by: RocSearch
... manager (PBM) in the US. The report begins with the history of the company; then describes in detail the profile of the senior management. It also analyzes the company’s PBM value chain and sales strategies.  |  more...
$950.00
Pricing & Reimbursement in Asia-Pacific
4/1/2006 | published by: Informa Healthcare
... products are reimbursed by the appropriate government agency or health insurer. Each country chapter details who is responsible for reimbursement, the processes for assessing a drug’s suitability for reimbursement in that country, recent changes, government ...  |  more...
$2,300.00
The Mail Service Pharmacy Market
6/1/1999 | published by: Kalorama Information
... in 1997. It examines the latest developments in the market, including the impact of managed care and pharmacy benefit management on the pharmaceutical industry. It provides U.S. market estimates for 1993-2003, and covers ten product ...  |  more...
$3,250.00
International Market For Mail Service Pharmacy
1/1/1996 | published by: Kalorama Information
... anti-infectives, cardiovascular drugs, diabetes drugs, diuretics, hormones, psychotropic drugs, respiratory drugs, ulcer medications, and other drugs. Assesses the international market and provides an overview of the healthcare market in key Western European countries and Canada.  |  more...
$1,625.00